Overview

BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight loss at the end of the second year of treatment (Week 104)
Phase:
Phase 3
Details
Lead Sponsor:
Arena Pharmaceuticals
Eisai Inc.